TAS-117

TAS-117 · Taiho Oncology, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TAS-117, covering 2021-04-22 to 2024-09-04. Get the full timeline:

Most recent: Clinical Trial Update: TAS-117 in Patients With Advanced Solid Tumors Harboring Germline PTEN Mutations [Phase 1]